FDA cleared the SpineLinc Anterior Cervical Implant System from Lincotek Medical on Dec 5, 2025 under K250764, a traditional 510(k). The device falls under product code ODP, Intervertebral Fusion Device With Bone Graft, Cervical, regulated at 21 CFR 888.3080 as a Class 2 device. The review panel was Orthopedic.
FDA logged the submission as received on Mar 13, 2025. The decision came 267 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
Lincotek Medical has one other decision in the tracker over the last 12 months: K252081 (SportLinc Syndesmosis Device).